Upregulation of AMPK Ameliorates Alzheimer’s Disease-Like Tau Pathology and Memory Impairment
出版年份 2020 全文链接
标题
Upregulation of AMPK Ameliorates Alzheimer’s Disease-Like Tau Pathology and Memory Impairment
作者
关键词
-
出版物
MOLECULAR NEUROBIOLOGY
Volume 57, Issue 8, Pages 3349-3361
出版商
Springer Science and Business Media LLC
发表日期
2020-06-10
DOI
10.1007/s12035-020-01955-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alzheimer’s Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies
- (2020) Jonathan Chang-Cheng Shieh et al. MOLECULAR NEUROBIOLOGY
- Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications
- (2019) Tanuj Joshi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of Nampt-Sirt6 Axis in Renal Proximal Tubules in Extracellular Matrix Deposition in Diabetic Nephropathy
- (2019) Hirokazu Muraoka et al. Cell Reports
- Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway
- (2019) Ge Liu et al. FASEB JOURNAL
- Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia
- (2019) Clifford R. Jack et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- AMPK: Potential Therapeutic Target for Alzheimer's disease
- (2019) Luping Yang et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Aging and Alzheimer's disease pathology
- (2019) Renpei Sengoku NEUROPATHOLOGY
- Oral microbiota and Alzheimer’s disease: Do all roads lead to Rome?
- (2019) Antoni Sureda et al. PHARMACOLOGICAL RESEARCH
- Alzheimer’s disease: A clinical perspective and future nonhuman primate research opportunities
- (2019) Rafi U. Haque et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial
- (2018) Anna Rosenberg et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Diabetes mellitus and Alzheimer’s disease: GSK-3β as a potential link
- (2018) Ying Zhang et al. BEHAVIOURAL BRAIN RESEARCH
- Activation of AMP-activated protein kinase (AMPK) aggravated postoperative cognitive dysfunction and pathogenesis in aged rats
- (2018) Mengya Cao et al. BRAIN RESEARCH
- Effect of intraperitoneal or intracerebroventricular injection of streptozotocin on learning and memory in mice
- (2018) Yang Zhang et al. Experimental and Therapeutic Medicine
- AMPK Activation Ameliorates Alzheimer's Disease-Like Pathology and Spatial Memory Impairment in a Streptozotocin-Induced Alzheimer's Disease Model in Rats
- (2018) Lai-Ling Du et al. JOURNAL OF ALZHEIMERS DISEASE
- Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance
- (2018) Jin-Liang Chen et al. EXPERIMENTAL NEUROLOGY
- Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer’s Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway
- (2017) Lin Wang et al. MOLECULAR NEUROBIOLOGY
- Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice
- (2016) Montasir Elahi et al. JOURNAL OF ALZHEIMERS DISEASE
- Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats
- (2016) N. Rajasekar et al. MOLECULAR NEUROBIOLOGY
- Chronic adiponectin deficiency leads to Alzheimer’s disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice
- (2016) Roy Chun-Laam Ng et al. Molecular Neurodegeneration
- Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer’s disease neuropathological deficits
- (2016) S A Shah et al. MOLECULAR PSYCHIATRY
- AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo
- (2016) Manon Domise et al. Scientific Reports
- Aging-associated formaldehyde-induced norepinephrine deficiency contributes to age-related memory decline
- (2015) Yufei Mei et al. AGING CELL
- Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice
- (2015) Jason K. Clark et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Estimation of PMI depends on the changes in ATP and its degradation products
- (2013) Shiwei Mao et al. Legal Medicine
- Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice
- (2013) Christoph Köhler et al. NEUROBIOLOGY OF AGING
- Activation of AMP-Activated Protein Kinase Alleviates Homocysteine-Mediated Neurotoxicity in SH-SY5Y Cells
- (2013) Youn-Jin Park et al. NEUROCHEMICAL RESEARCH
- Fear Learning Enhances Neural Responses to Threat-Predictive Sensory Stimuli
- (2013) M. D. Kass et al. SCIENCE
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and β-amyloid in neurons
- (2011) Steven J. Greco et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure
- (2011) Claire Thornton et al. BIOCHEMICAL JOURNAL
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant
- (2011) A. Sydow et al. JOURNAL OF NEUROSCIENCE
- Post-translational modifications of tau protein: Implications for Alzheimer's disease
- (2011) Ludovic Martin et al. NEUROCHEMISTRY INTERNATIONAL
- Mechanism for long-term memory formation when synaptic strengthening is impaired
- (2011) K. Radwanska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathies
- (2010) Valérie Vingtdeux et al. ACTA NEUROPATHOLOGICA
- Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis
- (2010) Je-Seong Won et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism
- (2010) Valérie Vingtdeux et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells
- (2009) Steven J. Greco et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
- AMP-activated Protein Kinase Activation Increases Phosphorylation of Glycogen Synthase Kinase 3β and Thereby Reduces cAMP-responsive Element Transcriptional Activity and Phosphoenolpyruvate Carboxykinase C Gene Expression in the Liver
- (2008) Nanao Horike et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started